DiaGen AI  /  Contact

Partner with DiaGen AI.

For platform access, catalog partnering or co-development enquiries.

Contact Us

Who to reach

DiaGen AI Team

Platform access. Enterprise use of BLACKCOMB and CYPRESS for small molecule and peptide programmes.

Catalog partnering. The DGEN1-5 KRAS catalog is pre-clinical, IP retained in full by DiaGen, and open to counterparties.

Co-development. Joint programmes on the model shared with Hadasit and UNC-SGC, where partners carry synthesis and validation.

Biosensor licensing. Modular biosensor plus AI analytics for diagnostics manufacturers.

NACanada & United States
EUUnited Kingdom & Europe
MENAUAE, via Dubai
APACJapan & Singapore

Send an enquiry

Tell us what you are working on.

We read every message and reply from IR@diagen.ai, usually within two business days.

Fields marked * are required. Your details are used only to respond to this enquiry.

Tech-Bio Partnering: Tools and Deployment

For platform access, catalog partnering or co-development enquiries.

IR@diagen.ai